Voyageur Mutual Funds has released its latest NPORT-P report, revealing its financial standing as of August 31, 2026. The report indicates that the fund has total assets of approximately $231.67 million and net assets of about $230.62 million. This filing is significant as it demonstrates the fund's ongoing transparency and commitment to its investors.
The report shows that Voyageur Mutual Funds operates in the investment sector, focusing primarily on municipal bonds. The filing highlights the fund's strategy in a competitive market, emphasizing its role in providing investors with access to tax-free income through its offerings.
Background
Voyageur Mutual Funds, identified by CIK 0000906236, is an investment company based in Philadelphia, Pennsylvania. The company has a history of focusing on mutual funds, particularly in the municipal bond sector. The most recent filings include multiple NPORT-P reports, showcasing its commitment to regular financial disclosures.
What the Filing Says
The NPORT-P filing, dated October 29, 2026, states that the fund's total assets amount to $231,671,489.66, with total liabilities of $1,052,638.93. The net assets are reported at $230,618,850.73. The filing indicates that the fund's investment strategy is centered around municipal bonds, reflecting a stable approach to asset management.
Impact
This update may affect current and potential investors in Voyageur Mutual Funds, as it provides a clear picture of the fund's financial health. It also positions the fund within the broader investment landscape, particularly in the municipal bond market, which is known for its tax advantages and stability.
What's Next
The filing does not specify what happens next for Voyageur Mutual Funds, but the regular updates suggest that the company will continue to provide transparency in its financial reporting.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






